6Falagas ME,Vardakas KZ,Michalopoulos A.In meta-analysis itraconazole is superior to fiuconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancies:response to Prentice et al.Br J Haematol.2006;132:658-659. 被引量:1
7S.B.Girois.F Chapuis.E.Decullier.B.G.P.Revol Adverse effects of antifhngal therapies in invasive fungal infections:review and meta-analysis Eur J Clin Microbiol InfEct.Dis(2006)25:138-149. 被引量:1
6VEROUX M, CORONA D, MACARONE M, et al. Caspofungin in kidney transplant recipients with refractory invasive candidiasis[J]. Nephrol Dial Transplant, 2007,22(5): 1487-1488. 被引量:1
7PASTICCI M B, BARCHIESI F M, FALLANI S M, et al.Clinical efficacy and tolerability of caspofimgin in a renal transplant patient with Aspergillus flavus lung infection: case report[J]. J Chemother,2006, 18(5): 549-553. 被引量:1
8TANG G, LID K. Modern Clinical Pharmacy (现代临床药物学) [M] . Beijing: Chemical Industry Press, 2003: 925. 被引量:1
9SANER F, GENSICKE J, RATH P, et al. Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in livertransplant patients[J].Infection, 2006,34(6): 328-332. 被引量:1
5Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasispersistent public health problem[J]. Clin Microbiol Rev, 2007, 20(1):133-163. 被引量:1
6Cheng MF, Yang YL, Yao TJ, et al. Risk factors for fatal candi-demia caused by Candida albicans and non -albicans Candida spe-cies[J]. BMC Infect Dis,2005,5:22. 被引量:1